Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al.

Bertoli AM, Font YM, Nadal A, Vil? LM. Differences between active treatment and placebo groups in the study of induction treatment of giant cell arteritis with high-dose glucocorticoids: comment on the article by Mazlumzadeh et al. Arthritis Rheum. 2007 May; 56(5):1723; author reply 1723-4.

View in: PubMed

subject areas

Acute-Phase Reaction
Anti-Inflammatory Agents
Blood Sedimentation
C-Reactive Protein
Dose-Response Relationship, Drug
Giant Cell Arteritis
Glucocorticoids
Humans
Methylprednisolone
Prednisone
Recurrence
Remission Induction

authors with profiles

Luis M. Vilá

RCMI CC is supported by the National Institute on Minority Health and Health Disparities, National Institutes of Health (NIH), through Grant Number U24MD015970. The contents of this site are solely the responsibility of the authors and do not necessarily represent the official views of the NIH

For technical support please contact support